Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11913449 | 1.00 | ALOX5 (0.60) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15959624 | 1.00 | ALOX5 (0.60) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL24599953 | 1.00 | ALOX5 (0.60) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL13060191 | 1.00 | ALOX5 (0.60) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15259625 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15259577 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15259624 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15259595 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL15259592 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL16656319 | 0.94 | ALOX5 (0.55) | ALOX5ALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110316926-A1 | Organic Phase Change Carriers Containing Nanoparticles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORPORATION (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110316926-A1 | Organic Phase Change Carriers Containing Nanoparticles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORPORATION (US) | 2011-12-29 | — | — | US | disclosed |
| US-20100116424-A1 | ORGANIC PHASE CHANGE CARRIERS CONTAINING NANOPARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100116424-A1 | ORGANIC PHASE CHANGE CARRIERS CONTAINING NANOPARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |